Infection with Mycobacterium avium Complex in Patients without Predisposing Conditions

New England Journal of Medicine

Volumn 321, Issue 13, 1989, Pages 863-868

  Prince, David S ^a   Peterson, Donald D ^a   Steiner, Robert M ^a   Gottlieb, Jonathan E ^a   Scott, Richard ^a   Israel, Harold L ^a   Figueroa, William G ^a   Fish, James E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; COUGHING; FEMALE; HUMAN; LUNG INFECTION; MALE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMAN; LUNG; MALE; MIDDLE AGE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 0024469590     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198909283211304     Document Type: Article

References (26)

1. Rosenzweig DY, Schlueter DP. Spectrum of clinical disease in pulmonary infection with Mycobacterium avium–intracellulare. Rev Infect Dis 1981; 3: 1046–51.
2. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135: 1007–14.
3. Hawkins CC, Gold JWM, Whimbey E, et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 184–8.
4. Zakowski P, Fligiel S, Berlin GW, Johnson BL Jr. Disseminated Mycobacterium avium–intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA 1982; 248: 2980–2.
5. Kiehn TE, Edwards FF, Brannon P, et al. Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol 1985; 21: 168–73.
6. Rosenzweig DY. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex: clinical features and course in 100 consecutive cases. Chest 1979; 75: 115–9.
7. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119: 107–59.
8. Yeager H Jr, Raleigh JW. Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis 1973; 108: 547–52.
9. Dutt AK, Stead WW. Long-term results of medical treatment in Mycobacterium intracellulare infection. Am J Med 1979; 67: 449–53.
10. Etzkom ET, Aldarondo S, McAllister CK, Matthews J, Ognibene AJ. Medical therapy of Mycobacterium avium–intracellulare pulmonary disease. Am Rev Respir Dis 1986; 134: 442–5.
11. Ahn CH, Ahn SS, Anderson RA, Murphy DT, Mammo A. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1986; 134: 438–41.
12. Homick DB, Dayton DC, Bedell GN, Fick RB Jr. Nontuberculous mycobacterial lung disease: substantiation of a less aggressive approach. Chest 1988; 93: 550–5.
13. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: Suppl 1S: 3S–15S.
14. Vestal AL. Procedures for the isolation and identification of mycobacteria. Atlanta: Centers for Disease Control, Department of Health, Education, and Welfare, 1975. (DHEW publication no. 75–8230.)
15. Wolinsky E. When is an infection disease? Rev Infect Dis 1981; 3: 1025–7.
16. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982; 146: 829–33.
17. Iseman MD, Corpe RF, O'Brien RJ, Rosenzwieg DY, Wolinsky E. Disease due to Mycobacterium avium–intracellulare. Chest 1985; 87: Suppl: 139S–149S.
18. Parker BC, Ford MA, Gruft H, Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis 1983; 128: 652–6.
19. Murphey SA, Jungkind DL, Schwartz HG, Adams K. Mycobacterium avium–intracellulare in a hospital hot water system: epidemiological investigation. In: Proceedings and abstracts of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, October 24–26, 1983. Washington, D.C.: American Society for Microbiology, 1983:277.
20. Kiblawi SS, Jay SJ, Stonehill RB, Norton J. Fever response of patients on therapy for pulmonary tuberculosis. Am Rev Respir Dis 1981; 123: 20–4.
21. Gribetz AR, Damsker B, Bottone EJ, Kirschner PA, Teirstein AS. Solitary pulmonary nodules due to nontuberculous mycobacterial infection. Am J Med 1981; 70: 39–43.
22. Christensen EE, Dietz GW, Ahn CH, et al. Pulmonary manifestations of Mycobacterium intracellularis. AJR 1979; 133: 59–66.
23. Christensen Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M. kansasii, and M. intracellularis infections. Chest 1981; 80: 132–6.
24. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982; 125: 388–91.
25. Albelda SM, Kern JA, Marinelli DL, Miller WT. Expanding spectrum of pulmonary disease caused by nontuberculous mycobacteria. Radiology 1985; 157: 289–96.
26. Davidson PT, Khanijo V, Goble M, Moulding TS. Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis 1981; 3: 1052–9.